Simplex Trading
ASND icon

Simplex Trading’s Ascendis Pharma A/S ASND Stock Holding History

Simplex Trading’s Portfolio ASND Stock Details ASND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$2.15M Buy
9,419
+1,144
+14% +$290K ﹤0.01% 1922
2026
Q2 		$2.21M Buy
+8,275
New +$1.93M ﹤0.01% 1936
2025
Q1 		– Sell
-6,288
Closed -$898K – 8471
2024
Q4 		$865K Buy
6,288
+4,354
+225% +$572K ﹤0.01% 2989
2024
Q3 		$288K Buy
+1,934
New +$261K ﹤0.01% 4170
2024
Q1 		– Sell
-2,270
Closed -$324K – 8807
2023
Q4 		$285K Buy
+2,270
New +$226K ﹤0.01% 4278
2023
Q3 		– Sell
-5,364
Closed -$502K – 8613
2023
Q2 		$478K Buy
+5,364
New +$467K ﹤0.01% 3363
2023
Q1 		– Sell
-1,617
Closed -$185K – 8960
2022
Q4 		$197K Buy
+1,617
New +$188K ﹤0.01% 4246
2021
Q4 		– Sell
-432
Closed -$64.3K – 10424
2021
Q3 		$58K Hold
432
– – ﹤0.01% 7331
2021
Q2 		$56K Sell
432
-1,562
-78% -$208K ﹤0.01% 7499
2021
Q1 		$256K Sell
1,994
-2,264
-53% -$344K ﹤0.01% 4351
2020
Q4 		$710K Buy
4,258
+3,095
+266% +$512K ﹤0.01% 2984
2020
Q3 		$179K Sell
1,163
-844
-42% -$121K ﹤0.01% 4247
2020
Q2 		$296K Sell
2,007
-5,927
-75% -$814K ﹤0.01% 3542
2020
Q1 		$893K Buy
+7,934
New +$1.03M ﹤0.01% 1992
2019
Q4 		– Sell
-5,284
Closed -$587K – 7255
2019
Q3 		$508K Buy
5,284
+551
+12% +$61.5K ﹤0.01% 2606
2019
Q2 		$545K Buy
+4,733
New +$566K ﹤0.01% 2478
2019
Q1 		– Sell
-14,993
Closed -$1.31M – 7094
2018
Q4 		$939K Buy
+14,993
New +$942K ﹤0.01% 1688
2018
Q3 		– Sell
-2,864
Closed -$197K – 7366
2018
Q2 		$190K Buy
+2,864
New +$188K ﹤0.01% 3539

Other funds holding ASND

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $195B AUM 21.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
Fidelity International
Fidelity International Hamilton, Bermuda $144B AUM 22.91% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
SEI Investments
SEI Investments Oaks, Pennsylvania $113B AUM 26.61% 1-Year Est. Return
ARS Investment Partners
ARS Investment Partners New York $2.23B AUM 74.02% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
USS Investment Management
USS Investment Management London, United Kingdom $25.1B AUM 30.53% 1-Year Est. Return

Simplex Trading's ASND Position: Q3 2026 in Review

Simplex Trading increased its Ascendis Pharma A/S (ASND) stake by 14% in Q3 2026, buying an estimated $290K and bringing the position to 9,419 shares worth $2.15M. The position accounts for ﹤0.01% of the portfolio, ranked #1922.

Simplex Trading first reported a position in ASND in Q2 2018 and has held it in 18 quarters since. The position peaked at $2.21M in Q2 2026. 156 funds tracked by Wall St. Rank hold ASND as of Q3 2026.

  • Simplex Trading held 9,419 shares of Ascendis Pharma A/S worth $2.15M as of Q3 2026.
  • Simplex Trading bought 1,144 Ascendis Pharma A/S shares in Q3 2026, an estimated $290K.
  • Ascendis Pharma A/S made up ﹤0.01% of Simplex Trading's portfolio in Q3 2026, its #1922 holding.
  • Simplex Trading first reported a position in Ascendis Pharma A/S in Q2 2018 and has held it in 18 quarters since.
  • Simplex Trading's Ascendis Pharma A/S position peaked at $2.21M in Q2 2026.
  • 156 funds tracked by Wall St. Rank held Ascendis Pharma A/S as of Q3 2026.

Based on Simplex Trading's 13F filing for Q3 2026, filed 4 Nov 2026.